PATENT CLAIM ANALYSIS

Application Number: 15975030
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "604000"]

Abstract:
Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor γ (RORγ) activity. This modulation has numerous effects, including inhibition of T H -17 cell function and/or T H -17 cell activity, and inhibition of re-stimulation of T H -17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of RORγ results in stimulation of T H -17 cell function and/or activity which is beneficial for immune-enhancing compositions (e.g., vaccines).

Claim (Index 4):
The method of  claim 1 , wherein the ROR\u03b3 agonist is orally administered.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.7
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13114616', '13766076', '13989973', '15087807', '13634073']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7685108500176484
- 35 USC 102 Novelty (BERT): 0.6641529703425546
- Combined Prediction Score: 0.758075062050139
- Mean Citation Score: 419.696068
- Max Citation Score: 639.10504
- Similarity Product: 617.6079671612837

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test